Ensemble Guided Fine-Tuning Pre-Trained Models for Kinase Inhibitor Design

Area of Science:

• Medicinal Chemistry
• Computational Biology
• Drug Discovery

Background:

• Protein kinases are crucial drug targets for complex diseases like cancer.
• Developing kinase inhibitors is challenging, with a low FDA approval rate despite numerous candidates.
• Data scarcity hinders the efficient discovery of novel kinase-targeted drugs.

Purpose of the Study:

• To introduce Ensemble Guide Fine-tuning (EGFit), an innovative framework for Pre-Trained Models.
• To address data scarcity challenges in kinase-targeted drug discovery.
• To enhance the generation of biologically relevant and structurally diverse kinase inhibitors.

Main Methods:

• EGFit integrates pre-trained large language models with machine learning techniques (Random Forest, SVM, MLP, Logistic Regression).
• The framework iteratively evaluates and refines generated compounds.
• Exploration of vast chemical spaces under limited data conditions.

Main Results:

• Experimental validation on EGFR, MET, PIM1, and CDK5 kinases showed improved compound similarity to known inhibitors.
• Generated compounds maintained drug-likeness criteria.
• The iterative feedback mechanism ensured chemical novelty and biological significance.

Conclusions:

• EGFit offers a scalable and effective solution for kinase drug discovery.
• The framework accelerates the development of novel kinase inhibitors.
• EGFit demonstrates potential for optimizing compound generation in kinase-specific applications.